Minimally invasive treatments of symptomatic benign prostatic hyperplasia (BPH) have been adopted by many centers for treatment of patients who fail pharmacological manipulation and cannot or do not ...

More than 250,000 people undergo a transurethral procedure each year in the U.S., and up to 10% of those people will experience a postoperative infection. Now, researchers from the University of ...

Transperineal laser ablation (TPLA) can be used to treat lower urinary tract symptoms of benign prostatic hyperplasia in the NHS while more evidence is generated, in people who cannot have ...

MINNEAPOLIS, May 6, 2026 /PRNewswire/ -- Francis Medical, Inc., a privately held medical device company based in Maple Grove, Minn., today announced that Naveen Kella, MD, of The Urology Place has ...

Benign prostatic hyperplasia (BPH) is a common condition that affects older people with a prostate. Stromal and epithelial cells increase in number, causing the prostate to get bigger. It often ...

Daniel Su, MD, a urologist at Orange County Urology Associates (OCUA), has performed the first commercial Vanquish® Water Vapor Ablation procedures in the state of California, offering patients a new ...

Transurethral resection of the prostate (TURP) is the gold standard treatment for obstructing benign prostatic hyperplasia (BPH), but it is limited to prostates weighing less than 100 g and is ...

The Society of Interventional Radiology (SIR) has published new practice guidance for the use of prostatic artery embolization (PAE) to treat enlarged prostate (also called benign prostatic ...

NHS savings could equate to millions of pounds per year, whilst reducing risks leading to better patient outcomes. New guidance has been released today by the National Institute for Health and Care ...

More than 250,000 people undergo a transurethral procedure each year in the U.S., and up to 10% of those people will experience a postoperative infection. But researchers have discovered an indicator ...